{
     "PMID": "9178960",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19970806",
     "LR": "20171030",
     "IS": "0364-3190 (Print) 0364-3190 (Linking)",
     "VI": "22",
     "IP": "6",
     "DP": "1997 Jun",
     "TI": "[3H]ketanserin binding in human brain postmortem.",
     "PG": "753-7",
     "AB": "This study aimed at comparing the binding characteristics of [3H]ketanserin, a high-affinity serotonin 2A (5-HT2A) receptor antagonist, in the prefrontal cortex, hippocampus and striatum of human brain post-mortem. The results indicated the presence of a single population of binding sites in all the regions investigated, with no statistical difference in maximum binding capacity (B(max)) or dissociation constant (K(d)) values. The pharmacological profile of [3H]ketanserin binding was consistent with the labeling of the 5-HT2A receptor, since it revealed a competing drug potency ranking of ketanserin = spiperone > clozapine = haloperidol > methysergide > mesulergine > 5-HT. In conclusion, the 5-HT2A receptor, as labeled by [3H]ketanserin, would seem to consist of a homogenous population of binding sites and to be equally distributed in human prefronto-cortical, limbic and extrapyramidal structures.",
     "FAU": [
          "Marazziti, D",
          "Rossi, A",
          "Palego, L",
          "Giannaccini, G",
          "Naccarato, A",
          "Lucacchini, A",
          "Cassano, G B"
     ],
     "AU": [
          "Marazziti D",
          "Rossi A",
          "Palego L",
          "Giannaccini G",
          "Naccarato A",
          "Lucacchini A",
          "Cassano GB"
     ],
     "AD": "Istituto di Psichiatria, Universita di Pisa, Roma, Italia. dmarazzipsico.med.unipi.it.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "United States",
     "TA": "Neurochem Res",
     "JT": "Neurochemical research",
     "JID": "7613461",
     "RN": [
          "97F9DE4CT4 (Ketanserin)"
     ],
     "SB": "IM",
     "MH": [
          "Autopsy",
          "Basal Ganglia/*metabolism",
          "Binding Sites",
          "Hippocampus/*metabolism",
          "Humans",
          "Ketanserin/*metabolism",
          "Prefrontal Cortex/*metabolism",
          "Radioligand Assay"
     ],
     "EDAT": "1997/06/01 00:00",
     "MHDA": "1997/06/01 00:01",
     "CRDT": [
          "1997/06/01 00:00"
     ],
     "PHST": [
          "1997/06/01 00:00 [pubmed]",
          "1997/06/01 00:01 [medline]",
          "1997/06/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neurochem Res. 1997 Jun;22(6):753-7.",
     "term": "hippocampus"
}